Fifth Lane Capital’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Fifth Lane Capital’s Portfolio PRTK Stock Details PRTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-261,781	Closed	-$579K	–	271
2023 Q2	$579K	Buy	+261,781	New	+$543K	0.17%	57

Fifth Lane Capital's PRTK Position: Q3 2023 in Review

Fifth Lane Capital sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2023, closing a stake of 261,781 shares — an estimated $579K sold.

Fifth Lane Capital first reported a position in PRTK in Q2 2023 and held it in 1 quarter. The position peaked at $579K in Q2 2023. 0 funds tracked by Wall St. Rank hold PRTK as of Q3 2023.

Fifth Lane Capital reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
Fifth Lane Capital sold 261,781 Paratek Pharmaceuticals, Inc. shares in Q3 2023, an estimated $579K.
Fifth Lane Capital first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2023 and held it in 1 quarter.
Fifth Lane Capital's Paratek Pharmaceuticals, Inc. position peaked at $579K in Q2 2023.
0 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2023.

Based on Fifth Lane Capital's 13F filing for Q3 2023, filed 14 Nov 2023.